EXCLUSIVE: Sen. John Cornyn praises BMS’s $2.3 billion Texas investment, credits Republican tax cuts
Sen. John Cornyn (R., Texas) is pointing to Bristol Myers Squibb’s massive new investment in Houston as evidence that Republicans’ Working Families Tax Cut is driving new investment and jobs in Texas.
BMS announced this week that it will invest $2.3 billion to build a 600,000-square-foot advanced manufacturing facility in Houston, a project expected to create nearly 500 permanent skilled jobs and roughly 2,000 construction jobs.
In an exclusive statement to the Washington Reporter, Cornyn credited Republican tax policy with helping make the investment possible.
“The Working Families Tax Cuts Act has helped keep Texas the best state in the country to build a business and create jobs, and Bristol Myers Squibb’s $2.3 billion investment in Houston is evidence of that,” Cornyn told the Reporter.
“I am proud to have voted for the WFTCA and am glad that it is continuing to boost domestic manufacturing while spurring new career opportunities for Texans.”
Cornyn played a major rule in the 2025 passage of the Working Families Tax Cut, having included several provisions that benefit middle-class Americans and strengthen the border security. Cornyn also successfully secured billions in reimbursement to Texas to pay for border security costs incurred during the Biden Administration.
A Senate Republican source told the Reporter, “John Cornyn has spent decades playing a major role in Texas’s economic success. He’s known for recruiting companies to Texas, passing economic policies that help Texas grow, and delivering. This is another win for the state and John deserves at least some credit.”
Cornyn’s comments come as Texas Republicans are increasingly highlighting the BMS announcement as a major economic win for the state.
Rep. August Pfluger (R., Texas) praised the investment, while Rep. Beth Van Duyne (R., Texas) also highlighted the announcement as evidence of continued economic growth in Texas.
The Senate Republican Conference pointed to the BMS investment as part of a broader wave of new investments under Republican economic policies.
The Republican praise follows the White House’s enthusiastic response to the announcement.
As the Reporter reported Monday, the White House, administration officials and conservative policy leaders quickly celebrated the project. White House Press Secretary Karoline Leavitt called the announcement the “Trump Effect.”
The Coalition for Affordability and Prosperity similarly called the investment a “game-changer” and argued that it showed companies are increasingly willing to make major long-term investments in the United States.
BMS has committed to investing $40 billion over five years in research, development, technology and manufacturing in the United States.
The company is also participating in TrumpRx, President Donald Trump’s effort to lower prescription drug costs for American patients. BMS was among nine major pharmaceutical companies that reached agreements with the administration last year to reduce prices while the White House pushes foreign countries to pay more for American-developed medicines.
The Houston manufacturing campus is expected to be completed around 2030.
